This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one.
The evidence for this is thinner than the way I have phrased it suggests.
I would call the community position on Robustness likely rather than established, and I would be comfortable defending that hedge.
Helpful, and easy to find again, which is half of what a good reply is.
Since Robustness keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will review it.
System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that appears on a certificate.
Post #34 is right about the mechanism and I think understates the practical bit.
Counterpoint on Robustness, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement rather than the process.
That has been true for the cases I have seen and I have not seen many.
Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition within reasonable ranges and demonstrating that results stay within acceptance.
It is the sort of thing that seems obvious in retrospect and was not at the time.
I read post #37 twice before replying, because I had assumed the opposite.
The version of Robustness that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those conditions are where the interesting cases live.
Post #37 answers the question as asked. The question underneath it is different.
The distinction between a qualified instrument and a validated method is worth keeping. Both are needed and they fail in different ways.
That is a description of practice, not a recommendation of it.
Marking my place. If it changes for me I will come back and say so.
Everything in post #40 holds. The case it does not cover is the one I have.
I keep a log for Robustness specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can separate them from the parent peak. Acceptance is that the method is stability-indicating.
Not a strong opinion, just a consistent one.
Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance. Almost nothing discussed here has one.
That is the shape of it. The detail is where I would expect to be corrected.
Source for the Robustness figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger than the paper is.
Reading the surrounding paragraph is worth the two minutes. The authors are more careful than their summarisers.
I read post #44 twice before replying, because I had assumed the opposite.
Precision has two levels worth distinguishing: repeatability within a run and intermediate precision across days, analysts and instruments. The second is where most methods lose the numbers people quote.
Post #46 is the version of this I will quote in future. One addition.
I changed my mind about Robustness after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way it happens.
Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow — and shows the result does not. It is the part of validation that predicts whether a method will transfer.
Robustness looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
I would keep Robustness and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them is why the last one went badly.
The arithmetic in post #51 is right; the assumption feeding it is the part to check.
The distinction between a qualified instrument and a validated method is worth keeping. Both are needed and they fail in different ways.
Reporting the observation and leaving the explanation open deliberately.
Two questions I would want answered before drawing anything from the Robustness data above: how were the cases selected, and what happened to the ones that dropped out.
Everything in post #55 holds. The case it does not cover is the one I have.
A method that reports the same number for every lot is worth a second look. Real processes vary, and a total absence of variation is a statement about the measurement rather than the process.
Adding the caveat now so it does not have to be extracted later.
Coming back to post #55, because the follow-up matters more than the original answer.
The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number.
I would rather be precise about what I do not know than vague about what I do.